header photo

Establishment of a new FDA-sponsored Botanical Safety Consortium

David is co-Chair of the Data Analysis working group in the new U.S. Food and Drug Administration (FDA) Botanical Safety Consortium, a public-private partnership of industry, academia, and government that will promote scientific advances in evaluating the safety of botanical ingredients and mixtures in dietary supplements. This group will look at novel ways to use cutting-edge toxicology tools, including alternatives to animal testing, to promote the goals of safety and effectiveness.



Go Back